The growing use of cost-effectiveness analysis (CEA) to evaluate specific interventions is dominated by studies of prospective new interventions compared with current practice. This type of analysis does not explicitly take a sectoral perspective in which the costs and effectiveness of all possible
Development of WHO guidelines on generalized cost-effectiveness analysis
β Scribed by Murray, Christopher J.L. (author);Evans, David B. (author);Acharya, Arnab (author);Baltussen, Rob M.P.M. (author)
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 140 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1057-9230
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Use of the person-years method for evaluating the association between treatment of a primary cancer and subsequent development of a second malignancy is reviewed. For this type of analysis, the risk of developing a second malignancy is implicitly assumed to remain constant during each patient's foll
## Abstract During the evaluation of a pretreatment method for the simultaneous quantification of four amyloid __Ξ²__βprotein fragments in transgenic mice plasma by a new gradient system, we have found that acetic acid has potency to completely dissolve plasma polypeptides in the presence of an orga